Goldman upgrades Reckitt as emerging markets, new products drive growth
Goldman Sachs upgraded Reckitt Benckiser to 'buy', citing accelerating sales growth and a 16% discount to sector earnings. It raised the price target to 6,500 pence and forecasts 4.5% organic sales growth in 2027-2028, driven by emerging markets and new products. Risks include litigation and lower-than-expected sales growth.
How this was made
The 30-second read
Why it matters
The upgrade could trigger short‑term buying and a price rally, especially if the market had previously priced in a neutral stance.
Market read
A fresh analyst upgrade with a higher price target provides a concrete catalyst for traders.
What to watch
Potential impact of the NEC litigation settlement and the size of the share buyback program.
Background
Goldman Sachs highlighted Reckitt's emerging‑market growth, new product launches, and margin expansion as reasons for the upgrade.
Ticker impact
Goldman Sachs upgraded Reckitt Benckiser to "buy" and raised its 12‑month price target to 6,500 pence.
likely upward pressure as investors price in the new target and valuation discount
Goldman's valuation thesis and higher target provide a clear catalyst for short‑term buying.
Market effects
The upgrade may lift other consumer‑staples names as the sector is seen as cheap relative to peers.
UK and European consumer‑staples markets could see modest gains.
Limited to investors tracking UK consumer stocks; no broad market effect.
Counterpoint
Some analysts may argue the upgrade is premature given litigation risks and modest growth.
Key entities
- companyReckitt Benckiser
Consumer health and hygiene group receiving the upgrade.
- analystGoldman Sachs
Upgraded the stock and set a new price target.



